ClinicalTrials.gg
CompletedNCT04156932Updated Feb 8, 2021

Closure of the Uterine Artery at Its Origin vs at the Cervix: a Randomized Trial

An interventional study of uterine artery closure in Anatomy, Laparoscopy and Uterine Artery, sponsored by Ospedale degli Infermi di Biella. Completed at 1 site in Italy. Open to female participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2021-02-08.

Sponsored by Ospedale degli Infermi di Biella · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
Female
01

Study summary

One of the fundamental surgical steps in patients undergoing laparoscopic hysterectomy is the closure of the uterine artery, this vessel provides the greatest blood supply to the uterus.

This step can be done in two ways: the surgeon can choose to interrupt the blood flow by closing the uterine artery in its last part, close to the uterus, or the surgeon can develop the anatomical spaces around the uterus into the deep pelvis, closing it to its origin, maintaining a minimally invasive approach in both cases.

Scientific research has tried to establish whether one of the two modalities is the best in reducing intraoperative blood loss and possible complications, but currently there is not enough evidence to recommend an approach rather than another.

The investigator has therefore decided to evaluate the results at the end of a laparoscopic hysterectomy in a scientifically rigorous manner.

02

Conditions studied

  • Anatomy
  • Laparoscopy
  • Uterine Artery
  • Hysterectomy
03

In context

Lead sponsor

Ospedale degli Infermi di Biella is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • benign disease
  • elective laparoscopic hysterectomy

Exclusion criteria

Exclusion Criteria:

  • malignant disease
  • emergency laparoscopic hysterectomy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    OUC

    Origin uterine artery closure

    Procedure: uterine artery closure

  • Active comparator
    IUC

    Cervical-isthmic uterine artery closure

    Procedure: uterine artery closure

Interventions

  • Procedureuterine artery closure

    Interruption the uterine blood flow by closing the uterine artery at its cervical-isthmic part or at its origin.

06

What researchers measure

Primary outcomes

  1. estimated blood loss

    ml

    Time frame: End of surgical procedure

07

Study locations

1 site
  • Ospedale degli Infermi
    Ponderano, Biella 13875, Italy
08

References and documents

Publications

  • Aarts JW, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BW, Kluivers KB. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD003677. doi: 10.1002/14651858.CD003677.pub5. PubMed 26264829 ↗
  • Aust T, Reyftmann L, Rosen D, Cario G, Chou D. Anterior approach to laparoscopic uterine artery ligation. J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):792-5. doi: 10.1016/j.jmig.2011.07.008. PubMed 22024265 ↗
  • Simpson NA, Nimrod C, De Vermette R, Leblanc C, Fournier J. Sonographic evaluation of intervillous flow in early pregnancy: use of echo-enhancement agents. Ultrasound Obstet Gynecol. 1998 Mar;11(3):204-8. doi: 10.1046/j.1469-0705.1998.11030204.x. PubMed 9589145 ↗
  • Uccella S, Cromi A, Casarin J, Bogani G, Serati M, Gisone B, Pinelli C, Fasola M, Ghezzi F. Minilaparoscopic versus standard laparoscopic hysterectomy for uteri >/= 16 weeks of gestation: surgical outcomes, postoperative quality of life, and cosmesis. J Laparoendosc Adv Surg Tech A. 2015 May;25(5):386-91. doi: 10.1089/lap.2014.0478. Epub 2015 Apr 3. PubMed 25839384 ↗
  • Uccella S, Cromi A, Serati M, Casarin J, Sturla D, Ghezzi F. Laparoscopic hysterectomy in case of uteri weighing >/=1 kilogram: a series of 71 cases and review of the literature. J Minim Invasive Gynecol. 2014 May-Jun;21(3):460-5. doi: 10.1016/j.jmig.2013.08.706. Epub 2013 Sep 4. PubMed 24012921 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2019 to primary completion in Aug 2020, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2019
First posted
Nov 8, 2019
StartActual
Dec 1, 2019
Primary completionActual
Aug 31, 2020
CompletionActual
Aug 31, 2020
Last update
Feb 8, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04156932
Lead sponsor
Ospedale degli Infermi di Biella
Responsible party
Sponsor
First posted
Nov 8, 2019
Start date
Dec 1, 2019
Primary completion
Aug 31, 2020
Completion
Aug 31, 2020
Last update
Feb 8, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion